 |
|
Sign in to view your progression
|
|
January 2020 │Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomized, placebo-controlled, phase 1 clinical trial
|
|
|
February 2020 | Vaccination of infants with meningococcal group B vaccine (4CMenB) in England
|
|
|
March 2020 | Fear and humour in the art of cholera
|
|
|
April 2020 | The psychological impact of quarantine and how to reduce it: rapid review of the evidence
|
|
|
May 2020 | School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review.
|
|
|
June 2020 | Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomized, placebo-controlled, phase 3 trial.
|
|
|
July 2020 | Preliminary results of two highly-anticipated COVID-19 vaccine trials
|
|
|
August 2020 | COVID-19 and multisystem inflammatory syndrome in children and adolescents
|
|
|
September 2020 | Baloxavir marboxil in Japanese pediatric patients with influenza: safety and clinical and virologic outcomes
|
|
|
October 2020 | Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants
|
|
|
November 2020 | Cerebrospinal Fluid Findings Are Poor Predictors of Appropriate FilmArray Meningitis/Encephalitis Panel Utilization in Pediatric Patients
|
|
|
December 2020 | Remdesivir does work… when to use it and what benefits might be expected is an open question
|
|
{{ help_message }}
{{filter}}